Tectonic Therapeutic (TECX) Other Non-Current Assets (2017 - 2026)
Tectonic Therapeutic (TECX) posted quarterly Other Non-Current Assets of $663000.0 for Q1 2026, up 12.95% year-over-year from $587000.0 in Q1 2025, and up 3.59% quarter-over-quarter from $640000.0 in Q4 2025.
Powered by 
Analysis
Tectonic Therapeutic (TECX) Other Non-Current Assets (2017 - 2026) Analysis & Trends
Tectonic Therapeutic (TECX) has reported Other Non-Current Assets for 10 consecutive years, with $663000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 12.95% year-over-year to $663000.0; the TTM figure through Mar 2026 stood at $663000.0 (up 12.95% YoY), while the FY2025 annual figure was $640000.0, up 310.26% from the prior year.
- Other Non-Current Assets advanced to $663000.0 in Q1 2026 per TECX's latest filing, from $640000.0 in the prior quarter.
- Across five years, Other Non-Current Assets topped out at $663000.0 in Q1 2026 and bottomed at $40000.0 in Q4 2022.
- Historically, Other Non-Current Assets has averaged $485352.9 across 5 years, with a median of $587000.0 in 2023.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets plunged 91.87% — and 2023, when it surged 1367.5%.
- Tectonic Therapeutic's Other Non-Current Assets stood at $40000.0 in 2022, then soared by 1367.5% to $587000.0 in 2023, then tumbled by 73.42% to $156000.0 in 2024, then jumped by 310.26% to $640000.0 in 2025, then rose by 3.59% to $663000.0 in 2026.
- Business Quant data shows TECX's Other Non-Current Assets at $663000.0 in Q1 2026, $640000.0 in Q4 2025, and $597000.0 in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.25 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 2.31 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 124.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 618.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 42.45 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 109.58 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 65.13 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 62.96 Mn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 104.44 Mn |
| 10 | Tectonic Therapeutic | 589.02 Mn | 589.02 Mn | - | 626,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 626,000.00 |
| Mar 31, 2026 | 663,000.00 |
| Dec 31, 2025 | 640,000.00 |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 587,000.00 |
| Mar 31, 2025 | 587,000.00 |
| Dec 31, 2024 | 587,000.00 |
| Sep 30, 2024 | 587,000.00 |
| Jun 30, 2024 | 587,000.00 |
| Mar 31, 2024 | 587,000.00 |
| Dec 31, 2023 | 669,000.00 |
| Sep 30, 2023 | 587,000.00 |
| Jun 30, 2023 | 587,000.00 |
| Mar 31, 2023 | 283,000.00 |
| Dec 31, 2022 | 40,000.00 |
| Sep 30, 2022 | 492,000.00 |
| Jun 30, 2022 | 492,000.00 |
| Mar 31, 2022 | 492,000.00 |
| Dec 31, 2021 | 492,000.00 |
| Sep 30, 2021 | 492,000.00 |